Skip to content

Mohamed Ghoweba, MD

NPI 1588286009ActiveIndividual· General Practice· Tyler, TX

General Practice (MD) in Tyler, Texas, licensed in TX, with an NPI issued in May 2020. Part D covered 120 prescriptions written in 2024, 31% of them generic. Novo Nordisk Inc reported $50.00 in payments in 2025, mostly food and beverage.

Overview

NPI1588286009
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedMay 7, 2020
Last updated in NPPESJun 29, 2026
Certified by providerJun 29, 2026

Specialties and licenses

TaxonomyCodeLicenseState
General Practice Primary208D00000XW2506TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)120 · 201 30-day fills
Patients38
Total drug cost$75,100
Generic share31% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$50.00 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Novo Nordisk Inc$50.001

What the 2025 payments were for

  • Food and Beverage$50.00 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other General Practice providers in Tyler

All General Practice providers in Texas →